Emergence of new SARS-CoV-2 Variant of Concern Omicron (B.1.1.529) - highlights Africa's research capabilities, but exposes major knowledge gaps, inequities of vaccine distribution, inadequacies in global COVID-19 response and control efforts

Petersen, Eskild, Ntoumi, Francine, Hui, David S , Abubakar, Aisha, Kramer, Laura D., Obiero, Christina, Tambyah, Paul Anantharajah, Blumberg, Lucille, Yapi, Richard, Al-Abri, Seif, Pinto, Tatiana de Castro Abreu, Yeboah-Manu, Dorothy, Haider, Najmul, Asogun, Danny, Velavan, Thirumalaisamy P., Kapata, Nathan, Bates, Matthew, Ansumana, Rashid, Montaldo, Chiara, Mucheleng'anga, Luchenga, Tembo, John, Mwaba, Peter, Himwaze, Cordelia M., Hamid, Muzamil Mahdi Abdel, Mfinanga, Sayoki, Mboera, Leonard, Raj, Tajudeen, Aklillu, Eleni, Veas, Francisco, Edwards, Sarah, Kaleebu, Pontiano, McHugh, Timothy D., Chakaya, Jeremiah, Nyirenda, Thomas, Bockarie, Moses, Nyasulu, Peter S, Wejse, Christian, Muyembe-Tamfum, Jean-Jacques, Azhar, Esam I., Maeurer, Markus, Nachega, Jean B., Kock, Richard, Ippolito, Giuseppe and Zumla, Alimuddin (2022) Emergence of new SARS-CoV-2 Variant of Concern Omicron (B.1.1.529) - highlights Africa's research capabilities, but exposes major knowledge gaps, inequities of vaccine distribution, inadequacies in global COVID-19 response and control efforts. International Journal of Infectious Diseases, 114 . pp. 268-272. ISSN 1201 9712

Full content URL: https://doi.org/10.1016/j.ijid.2021.11.040

Documents
Emergence of new SARS-CoV-2 Variant of Concern Omicron (B.1.1.529) - highlights Africa's research capabilities, but exposes major knowledge gaps, inequities of vaccine distribution, inadequacies in global COVID-19 response and control efforts
Published Open Access manuscript
[img]
[Download]
[img]
Preview
PDF
IJID Omicron editorial.pdf - Whole Document
Available under License Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International.

393kB
Item Type:Article
Item Status:Live Archive

Abstract

Nearly two years since the start of the SARS-CoV-2 pandemic, which has caused over 5 million deaths, the world continues to be on high COVID-19 alert. The World Health Organization (WHO), in collaboration with national authorities, public health institutions and scientists have been closely monitoring and assessing the evolution of SARS-CoV-2 since January 2020 (WHO 2021a; WHO 2021b). The emergence of specific SARS-CoV-2 variants were characterised as Variant of Interest (VOI) and Variant of Concern (VOC), to prioritise global monitoring and research, and to inform the ongoing global response to the COVID-19 pandemic. The WHO and its international sequencing networks continuously monitor SARS-CoV-2 mutations and inform countries about any changes that may be needed to respond to the variant, and prevent its spread where feasible. Multiple variants of the virus have emerged and become dominant in many countries since January 2021, with the Alpha, Beta, Gamma and Delta variants being the most prominent to date. (Table 1).

Keywords:SARS-CoV-2; omicron;
Subjects:A Medicine and Dentistry > A300 Clinical Medicine
Divisions:College of Science > School of Life Sciences
ID Code:48671
Deposited On:24 Mar 2022 13:50

Repository Staff Only: item control page